Rudy Lai

AI @ McKesson

Pharmaceutical distributor
Industry
Last updated
July 3, 2025 at 10:44 AM

Summary

  • McKesson has progressively integrated AI technologies since 2019, leveraging cloud platforms like Google Cloud and Microsoft Azure to enhance healthcare data management and predictive analytics, particularly in oncology and supply chain operations.
  • Recent initiatives include Ontada's collaboration with Microsoft to utilize Azure OpenAI for transforming unstructured oncology data, reflecting a shift to generative AI applications that improve clinical insights and operational efficiency.
  • AI adoption at McKesson spans reducing administrative burdens, enabling predictive supply chain analytics, deploying interactive virtual assistants for customer engagement, and developing specialty pharmacy solutions, indicating an increasing maturity and strategic focus on AI to improve customer experience and reduce costs.

VIBE METER

More AI announcements = more VIBE
Q1 23Q2 23Q3 23Q4 23Q1 24Q2 24Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26🔥🔥🔥🔥

4 AI Use Cases at McKesson

Administrative Automation
2026
Traditional
Generative
Agentic
Outcome
Costs
McKesson deploys AI to reduce administrative task burdens in healthcare, streamlining workflows so providers can focus more on patient care and clinical outcomes. [1]
Data Extraction
2025
Traditional
Generative
Agentic
Outcome
By leveraging large language models through Microsoft Azure OpenAI Service, McKesson's Ontada platform automates extraction and processing of complex unstructured oncology data to improve clinical decision-making efficacy. [1][2]
Supply Prediction
2024
Traditional
Generative
Agentic
Outcome
Risk
McKesson employs predictive analytics and AI to anticipate supply disruptions and shortages in their healthcare supply chain, enabling proactive management to maintain efficiency and avoid shortages. [1]
Customer Engagement
2022
Customer Facing
Traditional
Generative
Agentic
Outcome
McKesson uses interactive virtual assistants, chatbots, and agent assistance technologies to streamline customer interactions and support, increasing organizational efficiency and improving customer service experience. [1]

Timeline

2026 Q2: no updates

2026 Q1

2 updates

McKesson reiterated that investments in data infrastructure, automation, and AI significantly contributed to increased sales and operational efficiencies, while actively recruiting AI and automation expertise.

2025 Q4

1 updates

McKesson expanded access to quality cancer care by leveraging advanced AI technologies and strategic partnerships to enhance oncology services.

2025 Q3

1 updates

Analysis highlighted McKesson’s AI strategic dominance leveraging logistics scale and Rx technology innovation in healthcare supply chain and medication management.

2025 Q2

2 updates

McKesson continued AI innovation by launching precision oncology consortium projects, AI integration architect roles, specialty pharmacy solutions, and exploring machine learning to address cost challenges.

2025 Q1

1 updates

Ontada leveraged Microsoft Azure AI Foundry and Azure OpenAI Service to process 150 million oncology data points, demonstrating large language models in clinical data extraction and analysis.

2024 Q4

2 updates

Ontada partnered with Microsoft and Datavant to transform unstructured oncology data using Azure OpenAI and accelerate oncology insights access, signaling advanced use of generative AI.

2024 Q3: no updates

2024 Q2

1 updates

Scaling AI and predictive analytics helped McKesson anticipate supply chain disruptions and shortages, showing maturity in AI-driven logistics applications.

2024 Q1

1 updates

The company revolutionized healthcare with innovative AI applications focused on efficiency and improvement in clinical outcomes.

2023 Q4

1 updates

McKesson showcased three AI use cases: partnerships, acquisitions, and corporate venture investments to implement AI solutions enhancing healthcare capabilities.

2023 Q3

1 updates

McKesson's Director of Enterprise Analytics highlighted using supervised and unsupervised machine learning models as the analytics foundation, emphasizing practical application of AI in enterprise data analysis.

2023 Q2

1 updates

AI began automating routine tasks in nuclear medicine, enabling nuclear medicine physicians to concentrate on advanced care through applied AI-driven analytics.

2023 Q1: no updates

2022 Q4: no updates

2022 Q3

1 updates

McKesson adopted AI-powered interactive virtual assistants and chatbots, improving organizational efficiencies, emphasizing AI's role in client communication and operational support.

2022 Q2: no updates

2022 Q1: no updates

2021 Q4: no updates

2021 Q3: no updates

2021 Q2: no updates

2021 Q1: no updates

2020 Q4: no updates

2020 Q3: no updates

2020 Q2: no updates

2020 Q1: no updates

2019 Q4: no updates

2019 Q3

1 updates

Focus on building digital infrastructure and AI investments internally indicated McKesson's strategy to facilitate healthcare AI initiatives for data-driven decision making.

2019 Q2

1 updates

McKesson began centralizing data management and implementing AI for healthcare predictions by partnering with Google Cloud, marking initial AI adoption to transform healthcare data infrastructure.